63 Views | 26 Downloads
Sunil Agarwal, MD, Michigan Opioid Prescribing Engagement Network, 2800 Plymouth Rd, North Campus Research Complex (NCRC) Bldg 16, Ann Arbor, MI 48109 Email: asuni@med.umich.edu
Drs Agarwal and Waljee had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: All authors. Acquisition, analysis, or interpretation of data: Agarwal, Bryan, Hu, Lee, Chua, Haffajee, Brummett, Waljee. Drafting of the manuscript: Agarwal, Bryan, Chua, Brummett, Waljee. Critical revision of the manuscript for important intellectual content: Agarwal, Hu, Lee, Chua, Haffajee, Brummett, Englesbe, Waljee. Statistical analysis: Agarwal, Bryan, Hu, Chua. Obtained funding: Waljee. Administrative, technical, or material support: Agarwal, Bryan, Lee, Waljee. Supervision: Lee, Haffajee, Brummett, Englesbe, Waljee.
Dr Lee reported receiving grants from Blue Cross Blue Shield of Michigan Foundation during the conduct of the study. Dr Haffajee reported receiving grants from National Center for Advancing Translational Sciences of the National Institutes of Health and the Centers for Disease Control and Prevention for the University of Michigan Injury Prevention Center during the conduct of the study. Dr Brummett reported receiving grants from the University of Michigan and Michigan Opioid Prescribing Engagement Network and the US Department of Health and Human Services, Institutional–Precision Health Initiative, Opioid Use Case, receiving grants from the National Institutes of Health National Institute on Drug Abuse Prevention of Iatrogenic Opioid Dependence After Surgery, and serving as a consultant for Heron Therapeutics during the conduct of the study; and receiving research funding from Neuros Medical Inc, serving as a consultant for Recro Pharma and Heron Therapeutics, and holding a patent for peripheral perineural dexmedetomidine licensed to the University of Michigan outside the submitted work. Dr Englesbe reported receiving grants from Blue Cross and Blue Shield of Michigan during the conduct of the study. Dr Waljee reported receiving grants from National Institutes of Health and grants from the Michigan Department of Health and Human Services during the conduct of the study and being an unpaid consultant for 3M Health Information Systems outside the submitted work. No other disclosures were reported.
Dr Waljee receives funding from the National Institute on Drug Abuse (grant RO1 DA042859), National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant P50 AR070600), the Michigan Department of Health and Human Services (grant E20180672-00 Michigan DHHS - MA-2018 Master Agreement Program), the Substance Abuse and Mental Health Administration (grant SAMHSA: E20180568-00 MA-2018 Master Agreement Program), and the Centers for Disease Control and Prevention (grant E20182818-00 MA-2018 Master Agreement Program). Dr Chua is supported by a career development award from the National Institute on Drug Abuse (grant 1K08DA048110-01). Additional funding was provided by the University of Michigan School Dean's Office—Michigan Genomics Initiative and Precision Health Initiative, by the American College of Surgeons and the American Foundation for Surgery of the Hand (Dr Waljee), and by the Michigan Department of Health and Human Services (Drs Brummett, Waljee, and Englesbe).
2019 Agarwal S et al. JAMA Network Open.